Corporate Investor

Updated:

Helsana HealthInvest

Helsana HealthInvest was formed in 2021 as the venture-capital arm of Helsana Group, Switzerland's largest health insurer. The group is majority-owned by...

Helsana HealthInvest logo

Helsana HealthInvest

Helsana HealthInvest was formed in 2021 as the venture-capital arm of Helsana Group, Switzerland's largest health insurer. The group is majority-owned by Fondation Sana (79%), with Verein Artisana holding the remaining 21%. Dr. Ralf Molitor serves as Managing Director, while Dr. Elisabeth Bourqui chairs the Board of Directors. The unit deploys capital from an evergreen fund, drawing entirely from Helsana Group's balance sheet without outside LPs. The firm targets early-stage healthcare companies in Europe and Israel. Its investment scope spans digital health platforms, care-delivery innovation, and adjacent healthcare services. Helsana HealthInvest does not disclose a standard ticket size but participates in direct equity rounds. The sole LP structure eliminates traditional fundraising cycles, allowing the team to concentrate on deal sourcing and portfolio support. The firm has cultivated co-investor relationships through the Compassana joint venture, partnering with Medbase, Hirslanden, Groupe Mutuel, and SWICA to build an integrated digital health ecosystem. Team size and deployment totals remain private. The firm is based in Dübendorf, outside Zurich, and belongs to two Swiss industry networks: SECA (Swiss Private Equity & Corporate Finance Association) and the Swiss Startup Association. These memberships place the investment team inside Switzerland's concentrated startup and private-markets community. No additional offices or adjacent philanthropic vehicles have been disclosed publicly. Recent operational events have not been made public through the firm's primary channels. The fund's architecture as a single-LP evergreen vehicle — one large health insurer supplying permanent capital — distinguishes it from both independent venture firms and multi-LP corporate venture arms. There is no external fundraising pressure and no fixed fund life. The structure ties the investment thesis directly to Helsana Group's strategic interest in healthcare innovation, but also concentrates governance entirely within the parent company's ownership circle.

General information

Firm type

Corporate Investor

Year founded

2021

AUM

Undisclosed

Location

Region

Europe

Country

Switzerland

City

Dübendorf

Corporate office

Dübendorf, Switzerland

Principals

Dr. Ralf Molitor

Managing Director

Dr. Elisabeth Bourqui

Chairwoman of the Board of Directors

Sector focus

Digital HealthHealthcare Services

Frequently asked questions

Who makes investment decisions at Helsana HealthInvest?

Dr. Ralf Molitor, the firm's Managing Director, leads investment decisions. Dr. Elisabeth Bourqui serves as Chairwoman of the Board of Directors. Specific investment committee members beyond the two named principals have not been publicly disclosed.

Does Helsana HealthInvest manage outside capital?

No. The firm operates an evergreen fund with a single LP: Helsana Group. It does not raise capital from third-party institutional investors or family offices.

How is Helsana HealthInvest's parent company structured?

Helsana Group is majority-owned by Fondation Sana (79%), with Verein Artisana holding a 21% minority stake. This foundation-led ownership model roots the insurer, and by extension its venture arm, in a nonprofit governance structure.

Does Helsana HealthInvest co-invest alongside other healthcare players?

Yes. The unit collaborates with Medbase, Hirslanden, Groupe Mutuel, and SWICA through the Compassana joint venture, an integrated digital health initiative. This brings multiple Swiss healthcare operators into shared deal flow and platform development.

What stage does Helsana HealthInvest target?

The firm focuses on early-stage healthcare companies in Europe and Israel. It operates an evergreen fund, giving it flexibility to hold positions for extended periods without the exit pressure typical of fixed-life venture funds.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Dübendorf Corporate Investor profiles